BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18345545)

  • 1. A phase I/II study to evaluate the toxicity and efficacy of accelerated fractionation radiotherapy for the palliation of dysphagia from carcinoma of the oesophagus.
    Kassam Z; Wong RK; Ringash J; Ung Y; Kamra J; DeBoer G; O'Brien M; Kim J; Loblaw DA; Wong S; Cummings B; Davey P
    Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):53-60. PubMed ID: 18345545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).
    Penniment MG; De Ieso PB; Harvey JA; Stephens S; Au HJ; O'Callaghan CJ; Kneebone A; Ngan SY; Ward IG; Roy R; Smith JG; Nijjar T; Biagi JJ; Mulroy LA; Wong R;
    Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):114-124. PubMed ID: 29248399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative radiotherapy in addition to self-expanding metal stent for improving dysphagia and survival in advanced oesophageal cancer (ROCS: Radiotherapy after Oesophageal Cancer Stenting): study protocol for a randomized controlled trial.
    Adamson D; Blazeby J; Nelson A; Hurt C; Nixon L; Fitzgibbon J; Crosby T; Staffurth J; Evans M; Kelly NH; Cohen D; Griffiths G; Byrne A
    Trials; 2014 Oct; 15():402. PubMed ID: 25336193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
    Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
    J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
    Bhatt L; Tirmazy S; Sothi S
    Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective trial of short-course radiotherapy plus chemotherapy for palliation of dysphagia from advanced esophageal cancer.
    Hayter CR; Huff-Winters C; Paszat L; Youssef YM; Shelley WE; Schulze K
    Radiother Oncol; 2000 Sep; 56(3):329-33. PubMed ID: 10974382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/II study of CHARTWEL with concurrent chemotherapy in locally advanced, inoperable carcinoma of the oesophagus.
    Harney J; Goodchild K; Phillips H; Glynne-Jones R; Hoskin PJ; Saunders MI
    Clin Oncol (R Coll Radiol); 2003 May; 15(3):109-14. PubMed ID: 12801046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliation of dysphagia.
    van der Bogt RD; Vermeulen BD; Reijm AN; Siersema PD; Spaander MCW
    Best Pract Res Clin Gastroenterol; 2018; 36-37():97-103. PubMed ID: 30551864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancer.
    McDermott RL; Armstrong JG; Thirion P; Dunne M; Finn M; Small C; Byrne M; O'Shea C; O'Sullivan L; Shannon A; Kelly E; Hacking DJ
    Radiother Oncol; 2018 May; 127(2):253-258. PubMed ID: 29548561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.
    Sur RK; Donde B; Levin VC; Mannell A
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):447-53. PubMed ID: 9457834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Palliative treatment of esophageal cancer with dysphagia: more favourable outcome from single-dose internal brachytherapy than from the placement of a self-expanding stent; a multicenter randomised study].
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2800-6. PubMed ID: 16385833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial.
    Homs MY; Steyerberg EW; Eijkenboom WM; Tilanus HW; Stalpers LJ; Bartelsman JF; van Lanschot JJ; Wijrdeman HK; Mulder CJ; Reinders JG; Boot H; Aleman BM; Kuipers EJ; Siersema PD
    Lancet; 2004 Oct 23-29; 364(9444):1497-504. PubMed ID: 15500894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma: the phase II PALAESTRA trial.
    Borg D; Sundberg J; Brun E; Kjellén E; Petersson K; Hermansson M; Johansson J; Eberhard J; Johnsson A
    Acta Oncol; 2020 Feb; 59(2):212-218. PubMed ID: 31564184
    [No Abstract]   [Full Text] [Related]  

  • 14. Short-Course 2-Dimensional Radiation Therapy in the Palliative Treatment of Esophageal Cancer in a Developing Country: A Phase II Study (Sharon Project).
    Deressa BT; Tigeneh W; Bogale N; Buwenge M; Morganti AG; Farina E
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):67-72. PubMed ID: 31622698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study.
    Caravatta L; Padula GD; Macchia G; Ferrandina G; Bonomo P; Deodato F; Massaccesi M; Mignogna S; Tambaro R; Rossi M; Flocco M; Scapati A; Scambia G; Pacelli F; Valentini V; Cellini N; Morganti AG
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e627-31. PubMed ID: 22580117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Palliative stenting for relief of dysphagia in patients with inoperable esophageal cancer: impact on quality of life.
    Madhusudhan C; Saluja SS; Pal S; Ahuja V; Saran P; Dash NR; Sahni P; Chattopadhyay TK
    Dis Esophagus; 2009; 22(4):331-6. PubMed ID: 19473211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study.
    Spencer GM; Thorpe SM; Blackman GM; Solano J; Tobias JS; Lovat LB; Bown SG
    Gut; 2002 Feb; 50(2):224-7. PubMed ID: 11788564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for dysphagia in oesophageal cancer.
    Sreedharan A; Harris K; Crellin A; Forman D; Everett SM
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005048. PubMed ID: 19821338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy enhances laser palliation of malignant dysphagia: a randomised study.
    Sargeant IR; Tobias JS; Blackman G; Thorpe S; Glover JR; Bown SG
    Gut; 1997 Mar; 40(3):362-9. PubMed ID: 9135526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Self-expanding metal stents for palliation of malignant oesophageal obstruction].
    Tolmácsi B; Rábai K; Szamosi T; Czeglédi Z; Gyökeres T; Zsigmond F; Banai J
    Magy Seb; 2009 Apr; 62(2):59-66. PubMed ID: 19386565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.